Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation

Resveratrol Facilitates Pain Attenuation in a Rat Model of Neuropathic Pain Through the Activation of Spinal Sirt1

(2013) Qin Yin et al.   REGIONAL ANESTHESIA AND PAIN MEDICINE

Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord

(2012) Ji-Hua Hu et al.   BRAIN RESEARCH

Potentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice

(2011) Sara González-Rodríguez et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Bone cancer pain

(2010) Juan Miguel Jimenez-Andrade et al.   Annals of the New York Academy of Sciences

Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model

(2010) Qin Yin et al.   BEHAVIOURAL PHARMACOLOGY

Spinal glia and chronic pain

(2010) James P. O'Callaghan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Bisphosphonates: Mechanism of Action and Role in Clinical Practice

(2009) Matthew T. Drake et al.   MAYO CLINIC PROCEEDINGS

Chemokines and pain mechanisms

(2008) Catherine Abbadie et al.   BRAIN RESEARCH REVIEWS

Has Pain Management in Cancer Patients with Bone Metastases Improved? A Seven-Year Review at An Outpatient Palliative Radiotherapy Clinic

(2008) Andrea M. Kirou-Mauro et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Spinal glial activation contributes to pathological pain states

(2008) Hong Cao et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Spinal changes associated with mechanical hypersensitivity in a model of Guillain–Barré syndrome

(2008) Livio Luongo et al.   NEUROSCIENCE LETTERS